Citigroup’s HilleVax HLVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-4,232
| Closed | -$8.42K | – | 6193 |
|
|
2025
Q2 | $8.42K | Sell |
4,232
-19,810
| -82% | -$36.2K | ﹤0.01% | 5215 |
|
|
2025
Q1 | $34.9K | Sell |
24,042
-1,034
| -4% | -$1.91K | ﹤0.01% | 4976 |
|
|
2024
Q4 | $51.9K | Buy |
25,076
+1,605
| +7% | +$3.01K | ﹤0.01% | 5078 |
|
|
2024
Q3 | $41.3K | Buy |
23,471
+16,438
| +234% | +$42.2K | ﹤0.01% | 5061 |
|
|
2024
Q2 | $102K | Buy |
7,033
+2,255
| +47% | +$31K | ﹤0.01% | 4201 |
|
|
2024
Q1 | $79.5K | Buy |
4,778
+1,001
| +27% | +$16K | ﹤0.01% | 4396 |
|
|
2023
Q4 | $60.6K | Buy |
3,777
+3,183
| +536% | +$42.3K | ﹤0.01% | 4433 |
|
|
2023
Q3 | $7.99K | Sell |
594
-6,640
| -92% | -$93.5K | ﹤0.01% | 4600 |
|
|
2023
Q2 | $124K | Buy |
7,234
+6,608
| +1,056% | +$102K | ﹤0.01% | 4138 |
|
|
2023
Q1 | $10.3K | Sell |
626
-193
| -24% | -$3.09K | ﹤0.01% | 4715 |
|
|
2022
Q4 | $13.7K | Buy |
819
+621
| +314% | +$11.2K | ﹤0.01% | 4729 |
|
|
2022
Q3 | $3K | Sell |
198
-597
| -75% | -$8.68K | ﹤0.01% | 5384 |
|
|
2022
Q2 | $9K | Buy |
+795
| New | +$9.44K | ﹤0.01% | 5402 |
|
Citigroup's HLVX Position: Q3 2025 in Review
Citigroup sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 4,232 shares — an estimated $8.42K sold.
Citigroup first reported a position in HLVX in Q2 2022 and held it in 13 quarters. The position peaked at $124K in Q2 2023. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.
- Citigroup reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
- Citigroup sold 4,232 HilleVax shares in Q3 2025, an estimated $8.42K.
- Citigroup first reported a position in HilleVax in Q2 2022 and held it in 13 quarters.
- Citigroup's HilleVax position peaked at $124K in Q2 2023.
- 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.
Based on Citigroup's 13F filing for Q3 2025, filed 10 Nov 2025.